PeriGen

As we celebrate International Women's Day, we acknowledge the critical role that women play in every facet of life and the urgent need for advancements in healthcare that specifically address their needs. A recent report highlighted that investing in women's health could unlock a trillion-dollar opportunity. As we continue to innovate, we stand with every woman who deserves access to better healthcare, better understanding, and better opportunities to live her healthiest life. Together, we can drive a future where women’s health is prioritized, and this trillion-dollar opportunity is realized. ??

PeriGen is proud to attend the Avera MARCH Center of Excellence 2025 Summit in Sioux Falls, SD. Healthcare leaders, researchers, and tribal communities will gather to focus on maternal health equity. The event highlights the need to improve maternal and neonatal outcomes in Native communities—work that aligns closely with what we do at PeriGen. We are committed to improving outcomes globally, ensuring that every mother and baby has access to high-quality care. If you’re attending the summit, be sure to stop by the PeriGen booth and connect with Meghan Smith MBA-HM, MSN, RNC-OB, C-EFM, CNML. We look forward to meaningful discussions and collaborations that drive real change in maternal health.

Rhythm & Readings: Monthly Tracing Review is a micro-learning series designed to enhance nurses' skills in fetal heart monitoring (FHM), contributing to better maternal and neonatal outcomes. PeriGen is proud to sponsor the series from Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) to provide ongoing education in this important area! These 15-minute-per-month micro-learning sessions feature FHM simulation tracing reviews that will equip you with essential knowledge to advance your practice. Each session will offer 0.25 nursing contact hours for a total of 3.0 nursing contact hours and count toward C-EFM certification maintenance. Learn more here: https://lnkd.in/gd69x7BT

Thank you Femtech Insider for covering our latest news! “With this clearance, clinicians can now utilize PeriGen’s analytics earlier in pregnancy, providing immediate benefits in clinical practice,” said John Parker, MD, Chief Medical Officer at PeriGen. “Extending our AI-driven fetal monitoring to 32 weeks allows providers to benefit from early warning of indeterminate and abnormal fetal heart rate patterns in preterm patients, supporting timely interventions for these high-risk pregnancies.”

For many high-risk pregnancies, increased monitoring begins at 32 weeks. Previously, PeriGen’s fetal heart rate analytics were available starting at 36 weeks, limiting their use for certain preterm patients. Approximately 8% of U.S. babies are born between 32 and 36 weeks gestation. By expanding the availability of AI-powered fetal monitoring technology to include these preterm patients, PeriGen can provide clinicians with additional tools to support high-risk pregnancies.

We're proud to announce that we have received FDA clearance for Patterns 3.0, expanding the use of our proprietary fetal heart rate pattern recognition technology from 36 weeks of gestational age to 32 weeks. These additional weeks of monitoring for high-risk pregnancies significantly increase the utility and impact of our solution, supporting antepartum and intrapartum fetal monitoring. "With this clearance, clinicians can now utilize PeriGen’s analytics earlier in pregnancy, providing immediate benefits in clinical practice. Extending our AI-driven fetal monitoring to 32 weeks allows providers to benefit from early warning of indeterminate and abnormal fetal heart rate patterns in preterm patients, supporting timely interventions for these high-risk pregnancies.” - John Parker, MD, Chief Medical Officer at PeriGen Read more here: https://lnkd.in/g-YqZDdi

“This gives physicians some additional data points, nurses some additional data points to make good decisions for moms. It has some alerting mechanisms on it that if the computer system is seeing a patient where mom’s blood pressure and respiratory rate is low, it’ll alert us to that. Labor and delivery is a really busy place so this vigilance that you need to take care of moms, sometimes you get distracted to tend to another patient, this will pull you back to that patient and alert you to it.” -Kimberlee McKay, MD F.A.C.O.G. - Avera Research Medical Director

Dr. Donna Neale,?University of Maryland Medical System?Maternal and Fetal Medicine specialist and medical director of NEST said it best: "By integrating our experienced nurses with cutting-edge AI technology, we are setting the highest benchmarks for safety and equity in maternal and fetal health care across our Labor and Delivery units. Over time, we also hope the data from NEST will contribute to nationwide research aimed at improving perinatal outcomes.” Congratulations to this incredible team on the launch of NEST! Read more:?https://lnkd.in/e3DHqcpR

What an incredible time at the AWHONN Leadership Development Conference in Seattle! It was inspiring to connect with so many passionate leaders who are driving change in the industry. Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) gave away 12 year-long subscriptions to Rhythm & Readings: Monthly Tracing Review as door prizes. Congratulations to the winners! ?? We're proud to sponsor this micro-learning series, which is designed to enhance nurses' skills in fetal heart monitoring (FHM), contributing to better outcomes for mothers and babies. These 15-minute-per-month micro-learning sessions feature FHM simulation tracing reviews that will equip you with essential knowledge to advance your practice. Each session offers 0.25 nursing contact hours, for a total of 3.0 nursing contact hours, and counts toward C-EFM certification maintenance. Sign up here: https://lnkd.in/gd69x7BT

The University of Maryland Medical System?(UMMS) has introduced NEST (Neonatal Outcomes impacted by Escalation Safety Telemetry), a remote fetal monitoring center designed to?provide an extra layer of safety?during labor and delivery. NEST combines the expertise of a dedicated team of?Labor and Delivery?nurses with?tools from PeriGen to monitor fetal heart rates and uterine contractions in real time across all UMMS hospitals. We’re proud to be part of this innovative initiative that’s improving maternal and fetal health outcomes across Maryland. Learn more: https://lnkd.in/e3DHqcpR